At a Glance
| Magnesium Glycinate | Mucuna Pruriens | |
|---|---|---|
| Class | Supplement | Supplement |
| Common Dose (oral) | 200–350 mg | 100–300 mg (L-DOPA equivalent) |
| Total Duration | 3–6.5 hrs | 1.8–4.5 hrs |
| Routes | Oral | Oral |
Magnesium Glycinate, a Supplement, and Mucuna Pruriens, a Supplement, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Supplements, meaning they share a common pharmacological foundation. They share 4 documented effects in common, with 4 effects unique to Magnesium Glycinate and 11 unique to Mucuna Pruriens. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Magnesium Glycinate | Mucuna Pruriens | |
|---|---|---|
| Class | Supplement | Supplement |
| Common Dose (oral) | 200–350 mg | 100–300 mg (L-DOPA equivalent) |
| Total Duration | 3–6.5 hrs | 1.8–4.5 hrs |
| Routes | Oral | Oral |
| Effects | 8 documented | 15 documented |
| Level | Magnesium Glycinate | Mucuna Pruriens |
|---|---|---|
| Threshold | 50 mg | 25 mg (L-DOPA equivalent) |
| Light | 100–150 mg | 50–100 mg (L-DOPA equivalent) |
| Common | 200–350 mg | 100–300 mg (L-DOPA equivalent) |
| Strong | 350–500 mg | 300–500 mg (L-DOPA equivalent) |
| Heavy | 500 mg | 600 mg (L-DOPA equivalent) |
Magnesium Glycinate
Mucuna Pruriens
No direct interaction data available between these substances. This does not mean the combination is safe.
No dangerous interactions recorded.
No dangerous interactions recorded.